EGFR and non-small cell lung carcinoma: We reported earlier that the activities of PI3K and AKT were upregulated by NSCLC cell treatment with nicotine or BDNF and downregulated by cell treatment with inhibitors against EGFR or IGF-1R and by propranolol [37].